Product Information

ORILISSA 200 MG TABLET is a brand product labeled by AbbVie Inc., priced at $21.9740 per EA under NDC 00074003956. Its NADAC has been published 384 times since Feb 20, 2019.

ORILISSA 200 MG TABLET

Elagolix

$21.9740per EA

Strength

200 mg/1

Manufacturer

AbbVie Inc.

NDC

00074003956

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ELAGOLIX SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA210450

On Market Since

7/23/2018

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors

Cytochrome P450 3A Inducers

Decreased GnRH Secretion

Gonadotropin Releasing Hormone Receptor Antagonist

Gonadotropin Releasing Hormone Receptor Antagonists

P-Glycoprotein Inhibitors

Price Statistics

The NADAC for ORILISSA 200 MG TABLET has been published 384 times since Feb 20, 2019, and over the history we have for it it has risen 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price	$21.9740 per EA
All-time high	$21.9740 (Jun 24, 2026)
All-time low	$14.6103 (Feb 20, 2019)
52-week high	$21.9740
52-week low	$20.8699
Median price	$18.1147
Average price	$18.1339
Largest weekly change	+7.4% (Jan 8, 2020)
Weeks tracked	384
Tracking since	Feb 20, 2019

Price History

0.0%

+0.1%

+0.3%

+5.3%

+5.0%

+15.5%

+31.3%

All

+50.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Elagolix market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ORILISSA 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ORILISSA 200 MG TABLET, manufactured by AbbVie Inc., is $21.9740 per EA (NDC 00074003956), effective Jun 24, 2026.

How has the price of ORILISSA 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for ORILISSA 200 MG TABLET has risen 50.4%. It has been tracked across 384 weekly CMS publications since Feb 20, 2019.

What are the highest and lowest recorded NADAC prices for ORILISSA 200 MG TABLET?

Since Feb 20, 2019, the NADAC for ORILISSA 200 MG TABLET has ranged from a low of $14.6103 (Feb 20, 2019) to a high of $21.9740 (Jun 24, 2026), with a median of $18.1147 per EA.

Are there cheaper alternatives to ORILISSA 200 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ORILISSA 200 MG TABLET, so no direct lower-cost alternative is listed.